The Potential of High Sensitivity Diagnostic Immunoassay Testing: Current Benefits and Future Capabilities | Beckman Coulter
Products & Solutions
Back
Products & Solutions
Core Disciplines
Chemistry Immunoassay Hematology Urinalysis Microbiology Blood Banking Clinical Decision Support Protein Chemistry Service
Workflow & Informatics
Automation Systems DxA 5000 Total Lab Automation DxA 5000 Fit Automation System Advanced Informatics Remisol Advance Middleware Remote Services & Diagnostics
Solutions For
Antimicrobial Resistance Advantaged Workflows Advancing Clinical Capabilities Pioneering Digital Hematology Neurology High Sensitivity Diagnostics Host Response to Infection Cardiovascular Disease Infectious Disease Diagnostics Diabetes Diagnostics Drug Monitoring & Detection Sepsis
Support
Back
Support
Account Support
How to Create Your Account Create Account Manage Account Settings View All Account Support
Product Support
DxS Service In Vitro Diagnostic Regulation (IVDR) Manage My Technical Documents Search for Technical Documents Safety Data Sheets (SDS/MSDS) Search for Software Downloads Technical Documents Overview Manage My Regulatory Notifications Manage My Warranties & Agreements Request Instrument Support View Services Information View All Product Support Access Quality Assurance Programs
Ordering Support
Order Status & Tracking Track My Invoices View Return/RMA Policy Get Help with Orders View All Ordering Support
Resources
Back
Resources
Product Training
Browse Learning Lab › Learning Lab Login ›
Education & Research
Webinars Posters Research Grants
Insights
Clinical Studies & Trends Case Studies Publications
Company
Back
Company
People & Culture
Overview Sustainability Meet Our Teams Inclusion & Belonging How We Work History and Innovation
Careers
Job Search › Programs & Grants Office Locations
News & Events
Awards & Recognition Newsroom Blog Events Calendar
Home / Resources / Webinars / Immunoassay Webinars / The Potential of High Sensitivity Diagnostic Immunoassay Testing: Current Benefits and Future Capabilities

The Potential of High Sensitivity Diagnostic Immunoassay Testing: Current Benefits and Future Capabilities

"Drs. Christenson and Levy explored the groundbreaking potential of high-sensitivity diagnostic immunoassay (IA) testing. They discussed how these advancements are transforming cardiac care and more.

In this conversation, Drs. Christenson and Levy considered the utility and impact of high-sensitivity technologies in diagnostic IA testing. They also reviewed the evolution and future of diagnostic IA testing, along with the benefits of increased sensitivity in cardiac care and other areas."

Products
Support
Company Newsletter
Beckman Coulter Life Sciences
Stay Connected
Products
Support
Company
Newsletter
Beckman Coulter Life Sciences
Stay Connected

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

 

© 2025 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners. Some products may not be available in your country or region. Please contact your Beckman Coulter sales representative or distributor for more information.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.